{"id":"methohexitone","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Anemia","Asthma","Chronic heart failure","Chronic obstructive lung disease","Hepatic failure","Hypertensive urgency","Kidney disease","Low blood pressure","Morbid obesity","Porphyria","Seizure disorder","Shock"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["methohexital","Brevimytal (Hikma, Germany)"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Neuronal acetylcholine receptor; alpha2/beta2, Glycine receptor subunit alpha-1, GABA-A receptor alpha-1/beta-3/gamma-2"},"_scrapedAt":"2026-03-27T23:34:27.678Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"General anesthesia","diseaseId":"general-anesthesia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Local anesthesia","diseaseId":"local-anesthesia","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05655754","phase":"PHASE4","title":"Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2022-11-01","conditions":"ECT, Depression","enrollment":100},{"nctId":"NCT02624050","phase":"NA","title":"Methohexital v Propofol as General Anesthetic in Patients on ACEIs or ARBs","status":"COMPLETED","sponsor":"Milton S. Hershey Medical Center","startDate":"2016-08-01","conditions":"Hypotension, Anesthesia","enrollment":51},{"nctId":"NCT04022226","phase":"EARLY_PHASE1","title":"EEG Characteristics in ECT","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2019-10-01","conditions":"Electroconvulsive Therapy, Direct Current Electroencephalogram, Ketamine","enrollment":11},{"nctId":"NCT04187196","phase":"PHASE4","title":"Comparison of Bolus Dosing of Methohexital and Propofol in Elective Direct Current Cardioversion","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2020-04-29","conditions":"Atrial Fibrillation, Atrial Flutter","enrollment":73},{"nctId":"NCT01881763","phase":"PHASE4","title":"Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2010-06","conditions":"Unipolar Depression, Bipolar Depression","enrollment":31},{"nctId":"NCT01907217","phase":"PHASE4","title":"Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression","status":"COMPLETED","sponsor":"St Patrick's Hospital, Ireland","startDate":"2008-05","conditions":"Depression","enrollment":138},{"nctId":"NCT02752724","phase":"NA","title":"Ketamine Anesthesia for Improvement of Depression in ECT","status":"COMPLETED","sponsor":"VA Puget Sound Health Care System","startDate":"2016-03","conditions":"Major Depressive Disorder","enrollment":52},{"nctId":"NCT01567852","phase":"NA","title":"Use of Ketamine vs Methohexital for Electroconvulsive Therapy (ECT) on Patient Recovery and Re-orientation Time","status":"COMPLETED","sponsor":"University of New Mexico","startDate":"2011-08","conditions":"Post-anesthesia Recovery, Orientation","enrollment":20},{"nctId":"NCT01309581","phase":"NA","title":"Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression","status":"TERMINATED","sponsor":"James Murrough","startDate":"2010-04","conditions":"Major Depression, Bipolar Depression","enrollment":3},{"nctId":"NCT01367119","phase":"NA","title":"Ketamine Anesthesia in Electroconvulsive Therapy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-05","conditions":"Depression","enrollment":38}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"ANTICHOLINERGIC SYNDROME"},{"count":3,"reaction":"APNOEA"},{"count":1,"reaction":"BLOOD PRESSURE DECREASED"},{"count":1,"reaction":"CARDIAC ARREST"},{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"DYSARTHRIA"},{"count":1,"reaction":"INJECTION SITE PAIN"},{"count":1,"reaction":"LOSS OF CONSCIOUSNESS"},{"count":1,"reaction":"NODAL ARRHYTHMIA"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Methohexitone","genericName":"Methohexitone","companyName":"St Patrick's Hospital, Ireland","companyId":"st-patrick-s-hospital-ireland","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}